| RS2147945853 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147945859 |
GJB1
|
Health Risk |
Likely pathogenic |
Hand muscle atrophy, Hand muscle atrophy |
| RS2147946042 |
KIDINS220
|
Health Risk |
Pathogenic |
— |
| RS2147946047 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS2147946105 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147946194 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147946234 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147946319 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147946477 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147946493 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS2147946914 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS2147947315 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147947336 |
KIDINS220
|
Health Risk |
Likely pathogenic |
KCNA1-related disorder, KCNA1-related disorder |
| RS2147947553 |
FOXP3
|
Health Risk |
Likely pathogenic |
Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome, Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome |
| RS2147948858 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147949090 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147949186 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147949202 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147949777 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147950429 |
ATRX
|
Health Risk |
Pathogenic |
Alpha thalassemia-X-linked intellectual disability syndrome, Alpha thalassemia-X-linked intellectual disability syndrome |
| RS2147953043 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147953060 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147953102 |
COL4A5
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2147954328 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Thyroid cancer |
| RS2147954334 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147954548 |
BPTF
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2147955072 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147955255 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147955813 |
KDM6A
|
Health Risk |
Likely pathogenic |
— |
| RS2147956337 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147956419 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147957369 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147958526 |
PHKA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147959076 |
KDM6A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2147959089 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147959120 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147959392 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2147959471 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147959671 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147959745 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147959756 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147959775 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147961498 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147961500 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147961992 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome 2, Noonan syndrome 2 |
| RS2147962049 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147962064 |
LZTR1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy, Schwannomatosis |
| RS2147962725 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147963152 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147963355 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147963446 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2147963975 |
PCNT
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147964011 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
LZTR1-related disorder, Hereditary cancer-predisposing syndrome |
| RS2147964025 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2147964053 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
LZTR1-related schwannomatosis, LZTR1-related schwannomatosis |
| RS2147964105 |
LZTR1
|
Health Risk |
Pathogenic |
Noonan syndrome, Noonan syndrome 10 |
| RS2147964938 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147964939 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147965105 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147965376 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147965388 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147965393 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147965456 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147965479 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147966059 |
LZTR1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147966067 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147966682 |
LZTR1
|
Health Risk |
Likely pathogenic |
— |
| RS2147967090 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS2147967332 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147967929 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147968114 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147968271 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147968331 |
LZTR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147968487 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147968505 |
LZTR1
|
Health Risk |
Likely pathogenic |
Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome |
| RS2147969206 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147969337 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147969560 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2147969603 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147970361 |
LZTR1
|
Health Risk |
Pathogenic |
— |
| RS2147970527 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2147970908 |
LZTR1
|
Health Risk |
Likely pathogenic |
— |
| RS2147971083 |
LZTR1
|
Health Risk |
Pathogenic |
Noonan syndrome 10, Noonan syndrome 10 |
| RS2147972073 |
PHKA2
|
Health Risk |
Likely pathogenic |
— |
| RS2147972085 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147973166 |
EFNB1
|
Health Risk |
Pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2147973177 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2147974770 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147974808 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147974833 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147974914 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147975020 |
COL4A5
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS2147975083 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147975121 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147975180 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147975189 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147975210 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147975941 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2147975970 |
COLEC11
|
Health Risk |
Pathogenic |
3MC syndrome 2, 3MC syndrome 2 |
| RS2147976439 |
EFNB1
|
Health Risk |
Pathogenic |
— |